Washington’s bioscience industry is an innovative and growing component of the overall U.S. economy. With a track record of generating high-quality jobs and steady growth, the bioscience industry has been a consistent engine for our economy and a key strength during past economic recessions. American innovation in bioscience helps support state and local communities in a variety of ways ranging from job creation, construction, tax revenues, and other economic impact values.

Driven by small-company innovators, the bioscience industry has also mobilized in an unprecedented manner to address the global COVID-19 pandemic, while continuing to develop other life-saving and life-enhancing products and services for the U.S. and the world. America’s bioscience industry as an innovator and economic driver has never been more important, both for our health and our economic stability.

Total Number of Facilities in Washington 22
Jobs Directly Supported by the Industry in Washington 43546
Annual Average Wage
$123108
Total Clinical Trials
847
Dollar Amount Invested in Clinical Trials
$295.7 Million
Clinical Trial Participants
25267
Total Clinical Trial Economic Impact
$783.5 Million

View Facilities By District

District Total Facilities in District View Facilities in District
WA01 3

Cerevast Medical, Inc.

CoCrystal Pharma, Inc.

Curevo, Inc.

WA05 1

Integrated Lipid Biofuels LLC

WA07 17

Archon Biosciences, Inc.

Arzeda

Aurion Biotech

Faraday Pharmaceuticals, Inc.

Fred Hutchinson Cancer Center

HDT Bio

Kineta, Inc

Life Science Washington

Lila Biologics, Inc.

NephroDI Therapeutics, Inc.

Omeros Corporation

Sana Biotechnology, Inc.

Seal Rock Therapeutics

Seed Intellectual Property Law Group LLP

Shape Therapeutics, Inc.

Vilya, Inc.

Wayfinder Biosciences

WA09 1

Talus Bioscience, Inc.